The landscape of cancer treatment is constantly evolving, with new evidence and clinical findings emerging at a rapid pace. The Oncology Pharmacists Connect conference, developed in partnership with the Hematology/Oncology Pharmacy Association (HOPA), is specifically designed for oncology pharmacists to navigate the gaps between research and real-world practice. This one-and-a-half day meeting features accredited continuing education sessions, interactive roundtables, and panel discussions, allowing attendees to engage directly with clinical specialists, managed care experts, and oncology pharmacists to discuss recently presented data, identify resources needed to successfully implement new therapies and make formulary decisions, examine challenges, and brainstorm solutions to meet organizational demands while improving patient outcomes. This collaborative format is designed to facilitate debate, shared problem-solving, and the exchange of best practices. The agenda has been carefully curated to focus on the most impactful data presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and the European Hematology Association (EHA) Hybrid Congress.
In addition to featured core sessions, interested attendees are encouraged to submit a poster to share their clinical research, innovative practice models, or quality improvement projects. The poster sessions provide an opportunity for attendees to share their expertise with a national audience and receive direct feedback on their work. Participants can also discover new initiatives and best practices being implemented in other institutions, fostering collaborative relationships with other pharmacists dedicated to advancing oncology care.
We encourage you to take advantage of this opportunity to network, share ideas, and leave with actionable insights to enhance your practice and meet the demands of a rapidly changing field.